PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
07-Jun-2021 Stable Isotope Labelled Compounds Market to Reach USD 340.76 Million, Globally by 2027 CDN Newswire
07-Jun-2021 Global Pharmaceutical Robots Market to boost at a 13.6% CAGR between 2020 to 2027 CDN Newswire
07-Jun-2021 Global Pharmaceutical Continuous Manufacturing Market to Exhibit at a 8.2% CAGR during the forecast period 2020-2027 CDN Newswire
07-Jun-2021 Algorics announces acquisition of Domain Clinical Data Sciences Algorics
07-Jun-2021 Global Anatomic Pathology Market to reach USD 49.62 billion by 2026 Analytical Research Cognizance
07-Jun-2021 Mirum Pharmaceuticals Appoints Veteran Biotechnology Executive Carol L. Brosgart, M.D. to Board of Directors Businesswire
07-Jun-2021 IVD Quality Control Market Top Growth Factors and Business Intelligence Markets and Markets
07-Jun-2021 Medical Device Reprocessing Market USD 1,754 Million : Increasing Use of Gastroenterology and Cardiology markets and markets
07-Jun-2021 Exelixis and Ipsen Announce Detailed Results from Phase 3 COSMIC-311 Pivotal Trial of Cabozantinib in Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer Presented at ASCO 2021 Businesswire
07-Jun-2021 Amneal Announces Dihydroergotamine (DHE) Autoinjector NDA for Migraines and Cluster Headaches Businesswire
07-Jun-2021 Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance) Businesswire
07-Jun-2021 Humanigen Announces Ken Trbovich Appointed as Senior Vice President, Investor Relations Businesswire
07-Jun-2021 Exelixis and Ipsen Announce Detailed Results from Phase 3 COSMIC-311 Pivotal Trial of Cabozantinib in Patients with Previously Treated Radioactive Iodine-Refractory Differentiated Thyroid Cancer Presented at ASCO 2021 Businesswire
07-Jun-2021 Charles River Laboratories Announces Long-Term Solar Contract for North American Operations Businesswire
07-Jun-2021 Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel Businesswire
07-Jun-2021 Melior Pharmaceuticals Announces Entry Into “Letter-of-Intent” for the Acquisition of Armesocarb by Adhera Therapeutics Businesswire
07-Jun-2021 Exelixis et Ipsen présentent lors de la réunion de l’ASCO 2021 les résultats détaillés de l’étude de Phase III évaluant le cabozantinib chez des patients atteints d’un cancer de la thyroïde différencié Businesswire
07-Jun-2021 Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents Businesswire
07-Jun-2021 Moderna Files for Conditional Marketing Approval for its COVID-19 Vaccine in Adolescents in the European Union Businesswire
07-Jun-2021 Reven Announces New Chief Operating Officer Businesswire